# The association between multimorbidity patterns and physical frailty among middle-aged and older community-dwelling adults: the mediating role of depressive symptoms

**Authors:** Yuhan Geng, Ming Zhou, Yangxiaoxue Liu, Tianshu Zhao, Jiali Zhang, Min Xin, Wenxin Wang, Gongzi Zhang, Liping Huang

PMC · DOI: 10.3389/fpubh.2025.1527982 · Frontiers in Public Health · 2025-05-01

## TL;DR

This study finds that certain combinations of chronic diseases increase frailty risk in older adults, with depression playing a key mediating role, especially in specific groups.

## Contribution

The study identifies specific multimorbidity patterns linked to frailty and quantifies the mediating role of depressive symptoms in Chinese adults.

## Key findings

- Two multimorbidity patterns significantly increased frailty risk compared to a non-specific pattern.
- Depression mediated 35.20% of the effect of multimorbidity on frailty, with higher mediation in adults aged 60+.
- In certain subgroups, depression fully mediated the impact of comorbidities on frailty.

## Abstract

This study aimed to investigate the association between multimorbidity and frailty, and the potential mediating role of depressive symptoms in Chinese middle-aged and older community-dwelling adults.

We selected a total of 5,232 adults with two or more chronic diseases from the China Health and Retirement Longitudinal Study (CHARLS) database. Clusters of participants with similar multimorbidity patterns were identified through fuzzy c-means cluster analyses. The cross-sectional association between multimorbidity and frailty was measured through logistic regression analyses. Mediation analysis was applied to examine direct and indirect associations within the counterfactual framework.

At baseline, we identified five multimorbidity patterns. Two of these patterns significantly increased the risk of frailty compared to a non-specific pattern. Depression mediated 35.20% of the effect of multimorbidity on frailty (p = 0.042). Notably, in adults aged 60 years and older, this mediation accounted for 69.84% of the total effect, surpassing the direct impact of multimorbidity on frailty. Among individuals with economic support (0.020, 95% CI: 0.002–0.040), high school education (0.062, 95% CI: 0.007–0.120), and no alcohol consumption (0.024, 95% CI: 0.003–0.050), depression entirely mediated the impact of comorbidities.

This study reveals strong links between specific multimorbidity patterns and physical frailty, with depression significantly mediating these effects, particularly in certain populations. Findings emphasize tailored mental health interventions’ necessity in specific groups.

## Full-text entities

- **Genes:** CECR (cat eye syndrome chromosome region) [NCBI Gene 1055] {aka CES}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** heart disease (MESH:D006331), function (MESH:D003291), declines in cardiopulmonary function and (MESH:D006323), cancer (MESH:D009369), slow gait speed (MESH:D020234), congestive heart failure (MESH:D006333), D (MESH:D014808), Depression (MESH:D003866), glaucoma (MESH:D005901), kidney disease (MESH:D007674), brain function (MESH:D001927), gastric ulcers (MESH:D013276), chronic inflammation (MESH:D007249), muscle atrophy (MESH:D009133), falls (MESH:C537863), stroke (MESH:D020521), coronary heart disease (MESH:D003327), Weight loss (MESH:D015431), hypertension (MESH:D006973), metabolic and (MESH:D008659), cardiometabolic (MESH:D024821), Disease of Respiratory system (MESH:D015619), arthritis (MESH:D001168), stomach or other digestive diseases (MESH:D013272), CHARLS (OMIM:603663), prostate diseases (MESH:D011469), fatty liver (MESH:D005234), anxiety (MESH:D001007), diabetes (MESH:D003920), fractures (MESH:D050723), physical (MESH:D059445), angina (MESH:D000787), chronic bronchitis (MESH:D029481), brain atrophy (MESH:C566985), sarcopenia (MESH:D055948), Cerebrovascular, respiratory, and hepatic diseases (MESH:D015769), Psychiatric (MESH:D001523), cardiovascular diseases (MESH:D002318), dyslipidemia (MESH:D050171), Cerebrovascular disease (MESH:D002561), exhaustion (MESH:D006359), memory-related (MESH:D008569), coagulation abnormalities (MESH:D001778), metabolic dysregulation (MESH:D021081), Hepatic disease (MESH:D056486), fatigue (MESH:D005221), Frailty (MESH:D000073496), muscle catabolism (MESH:D019042), insulin resistance (MESH:D007333), liver disease (MESH:D008107), Chronic disease (MESH:D002908), chronic kidney disease (MESH:D051436), mobility impairments (MESH:D014086), emphysema (MESH:D004646), chronic lung diseases (MESH:D029424), Parkinson's disease (MESH:D010300), dementia (MESH:D003704), cognitive decline (MESH:D003072), cardiovascular, respiratory &amp; hepatic diseases (MESH:D012140), Weakness (MESH:D018908)
- **Chemicals:** Alcohol (MESH:D000438), cholesterol (MESH:D002784), blood sugar (MESH:D001786)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12078149/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12078149/full.md

## References

72 references — full list in the complete paper: https://tomesphere.com/paper/PMC12078149/full.md

---
Source: https://tomesphere.com/paper/PMC12078149